Evidence map›Paper›PMID 24918291›Full record

ArticleInternational journal of molecular sciences2014

Functional characterization of NIPBL physiological splice variants and eight splicing mutations in patients with Cornelia de Lange syndrome.

María E Teresa-Rodrigo, Juliane Eckhold, Beatriz Puisac, Andreas Dalski, María C Gil-Rodríguez, Diana Braunholz, Carolina Baquero, María Hernández-Marcos, Juan C de Karam, Milagros Ciero and 8 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. De novoMedicina (Kaunas, Lithuania) · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mosaic IntronicFrontiers in genetics · 2018
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 5 countries.

María E Teresa-RodrigoUnit of Clinical Genetics and Functional Genomics, Departments of Pharmacology-Physiology and Pediatrics, School of Medicine, University of Zaragoza, E-50009 Zaragoza, Spain. eteresa@unizar.es.
Juliane EckholdSektion für Funktionelle Genetik am Institut für Humangenetik, Universität zu Lübeck, D-23538 Lübeck, Germany. Juliane.Eckhold@uksh.de.
Beatriz PuisacUnit of Clinical Genetics and Functional Genomics, Departments of Pharmacology-Physiology and Pediatrics, School of Medicine, University of Zaragoza, E-50009 Zaragoza, Spain. puisac@unizar.es.
Andreas DalskiInstitut für Humangenetik, Universität zu Lübeck, D-23538 Lübeck, Germany. andreas.dalski@uksh.de.
María C Gil-RodríguezUnit of Clinical Genetics and Functional Genomics, Departments of Pharmacology-Physiology and Pediatrics, School of Medicine, University of Zaragoza, E-50009 Zaragoza, Spain. mcgil@unizar.es.
Diana BraunholzSektion für Funktionelle Genetik am Institut für Humangenetik, Universität zu Lübeck, D-23538 Lübeck, Germany. Diana.Braunholz@uksh.de.
Carolina BaqueroUnit of Clinical Genetics and Functional Genomics, Departments of Pharmacology-Physiology and Pediatrics, School of Medicine, University of Zaragoza, E-50009 Zaragoza, Spain. carobaque@gmail.com.
María Hernández-MarcosUnit of Clinical Genetics and Functional Genomics, Departments of Pharmacology-Physiology and Pediatrics, School of Medicine, University of Zaragoza, E-50009 Zaragoza, Spain. mhmarcos@unizar.es.
Juan C de KaramUnit of Clinical Genetics and Functional Genomics, Departments of Pharmacology-Physiology and Pediatrics, School of Medicine, University of Zaragoza, E-50009 Zaragoza, Spain. ckaram78@yahoo.es.
Milagros CieroUnit of Clinical Genetics and Functional Genomics, Departments of Pharmacology-Physiology and Pediatrics, School of Medicine, University of Zaragoza, E-50009 Zaragoza, Spain. milagrosciero2005@yahoo.es.
Fernando Santos-SimarroInstitute of Medical and Molecular Genetics, Hospital Universitario La Paz, E-28046 Madrid, Spain. fernando.santos@salud.madrid.org.
Pablo LapunzinaInstitute of Medical and Molecular Genetics, Hospital Universitario La Paz, E-28046 Madrid, Spain. plapunzina.hulp@salud.madrid.org.
Jolanta WierzbaDepartment of Pediatrics, Hematology, Oncology and Endocrinology and Department of General Nursery Medical University of Gdańsk, P80-211 Gdańsk, Poland. kwierz@gumed.edu.pl.
César H CasaleDepartment of Molecular Biology, Science School, National University of Rio Cuarto, 5800 Córdoba, Argentina. ccasale@exa.unrc.edu.ar.
Feliciano J RamosUnit of Clinical Genetics and Functional Genomics, Departments of Pharmacology-Physiology and Pediatrics, School of Medicine, University of Zaragoza, E-50009 Zaragoza, Spain. framos@unizar.es.
Gabriele Gillessen-KaesbachInstitut für Humangenetik, Universität zu Lübeck, D-23538 Lübeck, Germany. G.Gillessen@uksh.de.
Frank J KaiserSektion für Funktionelle Genetik am Institut für Humangenetik, Universität zu Lübeck, D-23538 Lübeck, Germany. frank.kaiser@uk-sh.de.
Juan PiéUnit of Clinical Genetics and Functional Genomics, Departments of Pharmacology-Physiology and Pediatrics, School of Medicine, University of Zaragoza, E-50009 Zaragoza, Spain. juanpie@unizar.es.
Universidad de Zaragoza · ESUniversity of Lübeck · DEHospital Universitario La Paz · ESGdańsk Medical University · PLNational University of Río Cuarto · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cornelia de Lange syndrome (CdLS) is a congenital developmental disorder characterized by distinctive craniofacial features, growth retardation, cognitive impairment, limb defects, hirsutism, and multisystem involvement. Mutations in five genes encoding structural components (SMC1A, SMC3, RAD21) or functionally associated factors (NIPBL, HDAC8) of the cohesin complex have been found in patients with CdLS. In about 60% of the patients, mutations in NIPBL could be identified. Interestingly, 17% of them are predicted to change normal splicing, however, detailed molecular investigations are often missing. Here, we report the first systematic study of the physiological splicing of the NIPBL gene, that would reveal the identification of four new splicing isoforms ΔE10, ΔE12, ΔE33,34, and B'. Furthermore, we have investigated nine mutations affecting splice-sites in the NIPBL gene identified in twelve CdLS patients. All mutations have been examined on the DNA and RNA level, as well as by in silico analyses. Although patients with mutations affecting NIPBL splicing show a broad clinical variability, the more severe phenotypes seem to be associated with aberrant transcripts resulting in a shift of the reading frame.

Indexed as

RNA SplicingAdolescentAdultCell Cycle ProteinsChildChild, PreschoolDe Lange SyndromeFemaleFrameshift MutationHumansInfantMalePhenotypeProtein IsoformsProteinsYoung AdultCell Cycle ProteinsNIPBL protein, humanProtein IsoformsProteins

Identifiers

PMID24918291
PMCPMC4100155
OpenAlexW1985000557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.